Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh Chen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|November 8, 2023
A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpointsWen Zhang, Glen Laird, Josh Chen, et al.
Journal of Biopharmaceutical Statistics|September 6, 2012
Qualitative consistency of treatment effects in multiregional clinical trialsYoko Tanaka, Gang Li, Yining Wang, et al.
Contemporary Clinical Trials|May 25, 2013
Consistency assessment with global and bridging development strategies in emerging marketsGang Li, Josh Chen, Hui Quan, et al.
Journal of Biopharmaceutical Statistics|April 17, 2025
PS-SAM: propensity-score-integrated self-adapting mixture prior to dynamically and efficiently borrow information from historical dataYuansong Zhao, Peng Yang, Glen Laird, et al.
Annals of Vascular Surgery|June 11, 2026
FINANCIAL IMPLICATIONS OF VASCULAR SURGERY CONFERENCE FEESAlexandra Kats, Gerard M Martin, Sanath Patil, et al.
Contemporary Clinical Trials|November 1, 2019
Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspectiveMing Zhu, Saranya Sridhar, Rosalind Hollingsworth, et al.
Contemporary Clinical Trials|April 30, 2017
Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trialsHui Quan, Xuezhou Mao, Yoko Tanaka, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect HeterogeneityGang Li, Hui Quan, Gordon Lan, et al.
The New England Journal of Medicine|June 14, 2018
Effect of Dengue Serostatus on Dengue Vaccine Safety and EfficacySaranya Sridhar, Alexander Luedtke, Edith Langevin, et al.
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|November 8, 2023
A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpointsWen Zhang, Glen Laird, Josh Chen, et al.
Journal of Biopharmaceutical Statistics|September 6, 2012
Qualitative consistency of treatment effects in multiregional clinical trialsYoko Tanaka, Gang Li, Yining Wang, et al.
Contemporary Clinical Trials|May 25, 2013
Consistency assessment with global and bridging development strategies in emerging marketsGang Li, Josh Chen, Hui Quan, et al.
Journal of Biopharmaceutical Statistics|April 17, 2025
PS-SAM: propensity-score-integrated self-adapting mixture prior to dynamically and efficiently borrow information from historical dataYuansong Zhao, Peng Yang, Glen Laird, et al.
Annals of Vascular Surgery|June 11, 2026
FINANCIAL IMPLICATIONS OF VASCULAR SURGERY CONFERENCE FEESAlexandra Kats, Gerard M Martin, Sanath Patil, et al.
Contemporary Clinical Trials|November 1, 2019
Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspectiveMing Zhu, Saranya Sridhar, Rosalind Hollingsworth, et al.
Contemporary Clinical Trials|April 30, 2017
Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trialsHui Quan, Xuezhou Mao, Yoko Tanaka, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect HeterogeneityGang Li, Hui Quan, Gordon Lan, et al.
The New England Journal of Medicine|June 14, 2018
Effect of Dengue Serostatus on Dengue Vaccine Safety and EfficacySaranya Sridhar, Alexander Luedtke, Edith Langevin, et al.
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Pageof 1